IT-Mac SB Capsule contains Itraconazole 50 mg, a broad-spectrum triazole antifungal agent indicated for the treatment of various fungal infections. Itraconazole works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. IT-Mac SB Capsule is effective against a wide range of dermatophytes, yeasts, and molds, including Candida species, Aspergillus species, and dermatophytes responsible for infections such as onychomycosis, tinea corporis, tinea cruris, and tinea pedis. The capsule formulation ensures optimal bioavailability and convenient oral administration. IT-Mac SB should be used under medical supervision, with dosage and duration tailored to the specific infection and patient response. Common adverse effects may include gastrointestinal disturbances, headache, and rash, while rare but serious effects involve hepatotoxicity and cardiac issues; hence, liver function and cardiac status should be monitored during prolonged therapy. Caution is advised in patients with hepatic impairment or congestive heart failure. IT-Mac SB Capsule may interact with several drugs metabolized by the cytochrome P450 system, necessitating careful review of concomitant medications. Overall, IT-Mac SB Capsule is a potent antifungal agent suitable for systemic fungal infections requiring effective and targeted therapy.